H2AX and neoplasm: In contrast, cisplatin-treated NPEPPS−/−(WT-FLAG) tumor cells exhibited lower levels of phospho-γ-H2AX, indicative of reduced exposure and sensitivity to cisplatin (Fig. 5D).